Cannabis products can pose severe medical risks when combined with commonly used medications such as blood thinners and antidepressants, particularly for seniors. Product labels fail to warn consumers of such dangers. According to a Canadian Pharmacist Association survey, 61% of medical cannabis users are self-medicating with no medical oversight. The association recommends pharmacists be involved in the management and distribution of medical cannabis products, providing guidance on safe use and potential drug interactions.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
